Skip to content

Inhibrx Biosciences, Inc. INBX Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$0.000.0%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$0.00
Summit Therapeutics logo
Summit TherapeuticsSMMT
Exelixis logo
ExelixisEXEL
Incyte logo
IncyteINCY
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+385%
Enterprise value$1.42B+982%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s preferred stock par value per share?
Inhibrx Biosciences, Inc. (INBX) reported preferred stock par value per share of $0.00 in Q1 2026.
How has Inhibrx Biosciences, Inc.'s preferred stock par value per share changed year-over-year?
Inhibrx Biosciences, Inc.'s preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What is the long-term trend for Inhibrx Biosciences, Inc.'s preferred stock par value per share?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.